[ Pharmaceutical Sciences Asia - ONLINE ]
Print ISSN 2586-8195 E-ISSN 2586-8470
[ Journal Abbreviation: Pharm.Sci.Asia ]
Mahidol University Journal of Pharmaceutical Sciences
  FORMER NAME   "Mahidol University Journal of Pharmaceutical Sciences" Published Since 1974

 
Abstracts

DOI: 10.29090/psa.2020.02.020.0026Pharm Sci Asia 2020; 47(2), 97-103
 

Pharmacological treatment for the Novel Coronavirus Disease 2019 (COVID-19 Infection)

Nattapong Tidwong1, 2*, Preecha Montakantikul2, Weerawat Manosuthi3

1 Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand
2 Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
3 Bamrasnaradura Infectious Diseases Institute, Nonthaburi, Thailand


As of March 22, 2020, a total of 292,142 confirmed coronavirus disease 2019 (COVID-19) cases have been reported globally. Although there are currently no specific antiviral agents but all coronaviruses shared similar key elements of target for currently approved antiviral or new drug development. Several agents might be considered as a possible treatment based on the efficacy in SARS and MERS.


Keyword:

Novel coronavirus; COVID-19; SARS-CoV-2; Antivirals




Download full paper (PDF File size: 350.18 KB.)





Vol.47
No.4
October - December 2020

See other volume

 


Vol.47
No.3
July - September 2020

See other volume

 


Vol.47
No.2
April - June 2020

See other volume

 


Vol.47
No.1
January - March 2020

See other volume

 
 
 

Home
Aims and Scope
Editorial Board
Publication Ethics
Instruction to Authors
Announcement
All Volumes & Issues
Submit Online
Contact us
   
Search
   
Faculty of Pharmacy Mahidol University
Mahidol University
Member's menu

You're now loging on with following account:
Guest (unknown)

Please Sign in or Register



    Copyright © 2017
    Faculty of Pharmacy, Mahidol University, THAILAND